Matthias Gijsen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Antibiotics (Basel, Switzerland)

Infection

The Journal of antimicrobial chemotherapy

Microorganisms

UZ Leuven

KU Leuven (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UZ Leuven

Belgium

Clinical Pharmacist :: Pharmacy Department

KU Leuven

Belgium

PhD researcher - Clinical Pharmacology and Pharmacotherapy :: Department of Pharmaceutical and Pharmacological Sciences

KU Leuven

Belgium

Clinical Pharmacist :: Pediatric Hematology-Oncology Department

Universitair Ziekenhuis Brussel

Belgium

Clinical Pharmacist :: Emergency Department

Education History

KU Leuven

Belgium

MSC

KU Leuven

Belgium

MSC

KU Leuven

Belgium

BSC

Publications

Angela Elma Edwina, Erwin Dreesen, Matthias Gijsen, Helena Cornelia van den Hout, Stefanie Desmet, Johan Flamaing, Lorenz Roger Van der Linden, Isabel Spriet, Jos Tournoy
Decreased Kidney Function Explains Higher Vancomycin Exposure in Older Adults. Drugs & aging (2024)
Dorian Vanneste, Matthias Gijsen, Johan A Maertens, Wim van Paesschen, Yves Debaveye, Joost Wauters, Isabel Spriet
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review. Infection 52 (3) (2024)
Valerie Caubergs, Evelyne Van den Broucke, Beatrijs Mertens, Matthias Gijsen, Willy E Peetermans, Eric Van Wijngaerden, Stefanie Desmet, Katrien Lagrou, Peter Declercq, Charlotte Quintens, Isabel Spriet
Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients. Infection (2024)
Indira Coenen, Lotte Vander Elst, Isabel Spriet, Matthias Gijsen, Veerle Foulon, De Lepeleire Jan, Katrien Latour, Veerle Cossey, Annette Schuermans, Nele Stroobants, Charlotte Quintens
Check of APpropriaTeness of Antimicrobial therapy In Nursing homes (CAPTAIN):a point prevalence study in Belgium. JAC-antimicrobial resistance 6 (4) (2024)
Perrin Ngougni Pokem, Dorian Vanneste, Stef Schouwenburg, Alan Abdulla, Matthias Gijsen, Evelyn Dhont, Dimitri van der Linden, Isabel Spriet, Pieter A J G de Cock, Birgit C P Koch, Françoise Van Bambeke, Gert-Jan Wijnant
Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy. Expert opinion on drug metabolism & toxicology (2024)
Barbara Deleenheer, Matthias Gijsen, Isabel Spriet, Tim Vanuytsel
Oral antimicrobial agents in patients with short bowel syndrome: the importance of considering TDM. The Journal of antimicrobial chemotherapy (2024)
Indira Coenen, Lotte Vander Elst, Isabel Spriet, Matthias Gijsen, Veerle Foulon, De Lepeleire Jan, Katrien Latour, Veerle Cossey, Annette Schuermans, Nele Stroobants, Charlotte Quintens
Check of APpropriaTeness of Antimicrobial therapy In Nursing homes (CAPTAIN):a point prevalence study in Belgium. JAC-antimicrobial resistance 6 (4) (2024)
Dorian Vanneste, Matthias Gijsen, Johan A Maertens, Wim van Paesschen, Yves Debaveye, Joost Wauters, Isabel Spriet
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review. Infection (2024)
Dorian Vanneste, Matthias Gijsen, Johan A Maertens, Wim van Paesschen, Yves Debaveye, Joost Wauters, Isabel Spriet
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review. Infection 52 (3) (2024)
Dorian Vanneste, Matthias Gijsen, Johan A Maertens, Wim van Paesschen, Yves Debaveye, Joost Wauters, Isabel Spriet
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature review. Infection 52 (3) (2024)
Chao-Yuan Huang, Fabian Güiza, Matthias Gijsen, Isabel Spriet, Dieter Frans Dauwe, Yves Debaveye, Marijke Peetermans, Joost Wauters, Greet Van den Berghe, Geert Meyfroidt, Greet De Vlieger
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients. Antibiotics (Basel, Switzerland) 12 (4) (2023)
André Wieringa, Tim M J Ewoldt, Ravish N Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J A R Kats, Isabel Spriet, Henrik Endeman, Jasper J Haringman, Reinier M van Hest, Birgit C P Koch, Alan Abdulla, null null
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Beatrijs Mertens, Omar Elkayal, Erwin Dreesen, Joost Wauters, Philippe Meersseman, Yves Debaveye, Karlien Degezelle, Pieter Vermeersch, Matthias Gijsen, Isabel Spriet
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics (Basel, Switzerland) 12 (7) (2023)
André Wieringa, Tim M J Ewoldt, Ravish N Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J A R Kats, Isabel Spriet, Henrik Endeman, Jasper J Haringman, Reinier M van Hest, Birgit C P Koch, Alan Abdulla, null null
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Chao-Yuan Huang, Fabian Güiza, Matthias Gijsen, Isabel Spriet, Dieter Frans Dauwe, Yves Debaveye, Marijke Peetermans, Joost Wauters, Greet Van den Berghe, Geert Meyfroidt, Greet De Vlieger
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients. Antibiotics (Basel, Switzerland) 12 (4) (2023)
André Wieringa, Tim M J Ewoldt, Ravish N Gangapersad, Matthias Gijsen, Nestor Parolya, Chantal J A R Kats, Isabel Spriet, Henrik Endeman, Jasper J Haringman, Reinier M van Hest, Birgit C P Koch, Alan Abdulla, null null
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Matthias Gijsen, Karel Allegaert
Editorial for the Special Issue: "Therapeutic Drug Monitoring of Antimicrobials". Antibiotics (Basel, Switzerland) 11 (6) (2022)
Matthias Gijsen, Erwin Dreesen, Joost Wauters, Yves Debaveye, Isabel Spriet
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis. Intensive care medicine 48 (6) (2022)
Evelyne Van den Broucke, Lore Thijs, Stefanie Desmet, Lotte Vander Elst, Matthias Gijsen, Marnix Mylemans, Otto Van de Gaer, Willy E Peetermans, Charlotte Quintens, Isabel Spriet
Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy. Pharmaceutics 14 (11) (2022)
Heleen Gastmans, Erwin Dreesen, Sebastian G Wicha, Nada Dia, Ellen Spreuwers, Annabel Dompas, Karel Allegaert, Stefanie Desmet, Katrien Lagrou, Willy E Peetermans, Yves Debaveye, Isabel Spriet, Matthias Gijsen
Systematic Comparison of Hospital-Wide Standard and Model-Based Therapeutic Drug Monitoring of Vancomycin in Adults. Pharmaceutics 14 (7) (2022)
Matthias Gijsen, Omar Elkayal, Pieter Annaert, Ruth Van Daele, Philippe Meersseman, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function. Infection and drug resistance 15 (2022)
Erwin Dreesen, Matthias Gijsen, Omar Elkayal, Pieter Annaert, Yves Debaveye, Joost Wauters, Mats O Karlsson, Isabel Spriet
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumonia. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Beatrijs Mertens, Ruth Van Daele, Yves Debaveye, Joost Wauters, Christophe Vandenbriele, Roger J M Brüggemann, Matthias Gijsen, Isabel Spriet
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy 77 (12) (2022)
Matthias Gijsen, Erwin Dreesen, Ruth Van Daele, Pieter Annaert, Yves Debaveye, Joost Wauters, Isabel Spriet
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study. Antibiotics (Basel, Switzerland) 10 (5) (2021)
Matthias Gijsen, Dirk Vlasselaers, Isabel Spriet, Karel Allegaert
Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine. Antibiotics (Basel, Switzerland) 10 (10) (2021)
Matthias Gijsen, Erwin Dreesen, Pieter Annaert, Johan Nicolai, Yves Debaveye, Joost Wauters, Isabel Spriet
Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis. Microorganisms 9 (6) (2021)
Matthias Gijsen, Benjamin Filtjens, Pieter Annaert, Yeghig Armoudjian, Yves Debaveye, Joost Wauters, Peter Slaets, Isabel Spriet
Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of Degradation. Antibiotics (Basel, Switzerland) 10 (4) (2021)
Ruth Van Daele, Joost Wauters, Pieter De Cock, Franky Buyle, John Leys, Pieter Van Brantegem, Matthias Gijsen, Pieter Annaert, Yves Debaveye, Katrien Lagrou, Willy E Peetermans, Roger J Brüggemann, Isabel Spriet
Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid. Antibiotics (Basel, Switzerland) 10 (9) (2021)
Ruth Van Daele, Joost Wauters, Katrien Lagrou, Raphaël Denooz, Marie-Pierre Hayette, Matthias Gijsen, Roger J Brüggemann, Yves Debaveye, Isabel Spriet
Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients. Microorganisms 9 (10) (2021)
Matthias Gijsen, Alexander Wilmer, Geert Meyfroidt, Joost Wauters, Isabel Spriet
Can augmented renal clearance be detected using estimators of glomerular filtration rate? Critical care (London, England) 24 (1) (2020)
Bing Qi, Matthias Gijsen, Pieter Van Brantegem, Tom De Vocht, Neel Deferm, Getahun Befirdu Abza, Nina Nauwelaerts, Joost Wauters, Isabel Spriet, Pieter Annaert
Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry. Drug testing and analysis 12 (8) (2020)

Matthias Gijsen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias Gijsen